Antimicrobial and resource utilization with T2 magnetic resonance for rapid diagnosis of bloodstream infections: systematic review with meta-analysis of controlled studies
- PMID: 33863237
- DOI: 10.1080/17434440.2021.1919508
Antimicrobial and resource utilization with T2 magnetic resonance for rapid diagnosis of bloodstream infections: systematic review with meta-analysis of controlled studies
Abstract
Objectives: To compare antimicrobial and resource utilization with T2 Magnetic Resonance (T2MR) versus blood culture (BC) in patients with suspected bloodstream infection.Methods: We systematically searched MEDLINE, EMBASE, and CENTRAL for randomized trials or observational controlled studies of patients with suspected bloodstream infection receiving a diagnosis with T2MR or BC. Using an inverse variance meta-analysis model, we reported mortality using the risk ratio (RR) and the remaining outcomes as the mean difference (MD).Results: Fourteen studies were included in the meta-analysis. Time to detection (MD = -81 hours; p < 0.001) and time to species identification (MD = -77 hours; p < 0.001) were faster with T2MR. Patients testing positive on T2MR received targeted antimicrobial therapy faster (-42 hours; p < 0.001) and patients testing negative on T2MR were de-escalated from empirical therapy faster (-7 hours; p = 0.02) vs. BC. Length of intensive care unit stay (MD = -5.0 days; p = 0.03) and hospital stay (MD = -4.8 days; p = 0.03) were shorter with T2MR. Mortality rates were comparable between T2MR and BC (28.9% vs. 29.9%, RR = 1.02, p = 0.86).Conclusion: Utilization of T2MR for identification of bloodstream pathogens provides faster time to detection, faster transition to targeted microbial therapy, faster de-escalation of empirical therapy, shorter ICU and hospital stay, and with comparable mortality rate versus BC.
Keywords: Bacteremia; T2Dx; blood culture; candida; magnetic resonance; sepsis.
Similar articles
-
Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19.Microbiol Spectr. 2022 Jun 29;10(3):e0014022. doi: 10.1128/spectrum.00140-22. Epub 2022 Jun 13. Microbiol Spectr. 2022. PMID: 35695564 Free PMC article.
-
A Retrospective Single-Center Analysis from Southern Italy on the Use of T2 Magnetic Resonance Assays as a Point-of-Care Method for Patients with Sepsis.Biomedicines. 2025 Apr 20;13(4):999. doi: 10.3390/biomedicines13040999. Biomedicines. 2025. PMID: 40299641 Free PMC article.
-
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience.BMC Infect Dis. 2022 Feb 1;22(1):113. doi: 10.1186/s12879-022-07096-w. BMC Infect Dis. 2022. PMID: 35105333 Free PMC article.
-
T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications.J Fungi (Basel). 2018 Apr 4;4(2):45. doi: 10.3390/jof4020045. J Fungi (Basel). 2018. PMID: 29617284 Free PMC article. Review.
-
Determining the optimal antibiotic regimen for chorioamnionitis: A systematic review and meta-analysis.Acta Obstet Gynecol Scand. 2021 May;100(5):818-831. doi: 10.1111/aogs.14044. Epub 2021 Jan 16. Acta Obstet Gynecol Scand. 2021. PMID: 33191493
Cited by
-
Evaluation of T2 Magnetic Resonance (T2MR®) Technology for the Early Detection of ESKAPEc Pathogens in Septic Patients.Antibiotics (Basel). 2024 Sep 14;13(9):885. doi: 10.3390/antibiotics13090885. Antibiotics (Basel). 2024. PMID: 39335058 Free PMC article.
-
Procalcitonin and Risk Prediction for Diagnosing Bacteremia in Hospitalized Patients: A Retrospective, National Observational Study.Diagnostics (Basel). 2023 Oct 11;13(20):3174. doi: 10.3390/diagnostics13203174. Diagnostics (Basel). 2023. PMID: 37891995 Free PMC article.
-
Accuracy and Impact on Patient Management of New Tools for Diagnosis of Sepsis: Experience with the T2 Magnetic Resonance Bacteria Panel.Pathogens. 2021 Sep 2;10(9):1132. doi: 10.3390/pathogens10091132. Pathogens. 2021. PMID: 34578164 Free PMC article.
-
Direct-from-Blood Detection of Pathogens: a Review of Technology and Challenges.J Clin Microbiol. 2023 Jul 20;61(7):e0023121. doi: 10.1128/jcm.00231-21. Epub 2023 May 24. J Clin Microbiol. 2023. PMID: 37222587 Free PMC article. Review.
-
Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms.Open Forum Infect Dis. 2022 Dec 1;10(1):ofac645. doi: 10.1093/ofid/ofac645. eCollection 2023 Jan. Open Forum Infect Dis. 2022. PMID: 36686626 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical